Cargando…

Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study

Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June–August 2021). An online questionnaire was...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerbier, Eva, Favre, Guillaume, Tauqeer, Fatima, Winterfeld, Ursula, Stojanov, Milos, Oliver, Alison, Passier, Anneke, Nordeng, Hedvig, Pomar, Léo, Baud, David, Panchaud, Alice, Meyer-Massetti, Carla, Ceulemans, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100043/
https://www.ncbi.nlm.nih.gov/pubmed/35564733
http://dx.doi.org/10.3390/ijerph19095335
_version_ 1784706756341923840
author Gerbier, Eva
Favre, Guillaume
Tauqeer, Fatima
Winterfeld, Ursula
Stojanov, Milos
Oliver, Alison
Passier, Anneke
Nordeng, Hedvig
Pomar, Léo
Baud, David
Panchaud, Alice
Meyer-Massetti, Carla
Ceulemans, Michael
author_facet Gerbier, Eva
Favre, Guillaume
Tauqeer, Fatima
Winterfeld, Ursula
Stojanov, Milos
Oliver, Alison
Passier, Anneke
Nordeng, Hedvig
Pomar, Léo
Baud, David
Panchaud, Alice
Meyer-Massetti, Carla
Ceulemans, Michael
author_sort Gerbier, Eva
collection PubMed
description Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June–August 2021). An online questionnaire was distributed in five European countries between June–August 2021. Pregnant women or women who had delivered in the three preceding months, and ≥18 years old, could participate. The prevalence of overall medication use, self-medication, and changes in chronic medication use were determined. A total of 2158 women out of 5210 participants (41.4%) used at least one medication. Analgesics (paracetamol), systemic antihistamines (cetirizine), and drugs for gastric disorders (omeprazole) were the three most used classes. Anti-infectives were less prevalent than during pre-pandemic times. Antidepressants and anxiety related medication use remained similar, despite a higher prevalence of these symptoms. Self-medication was reported in 19.4% of women, and 4.1% of chronic medication users reported that they changed a chronic medication on personal initiative due to the pandemic. In conclusion, medication use patterns in our cohort were mostly similar to those of the first COVID-19 wave and the pre-pandemic period. More studies are needed to explore factors associated with self-medication and changes in chronic medication use due to the pandemic in this perinatal population.
format Online
Article
Text
id pubmed-9100043
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91000432022-05-14 Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study Gerbier, Eva Favre, Guillaume Tauqeer, Fatima Winterfeld, Ursula Stojanov, Milos Oliver, Alison Passier, Anneke Nordeng, Hedvig Pomar, Léo Baud, David Panchaud, Alice Meyer-Massetti, Carla Ceulemans, Michael Int J Environ Res Public Health Article Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June–August 2021). An online questionnaire was distributed in five European countries between June–August 2021. Pregnant women or women who had delivered in the three preceding months, and ≥18 years old, could participate. The prevalence of overall medication use, self-medication, and changes in chronic medication use were determined. A total of 2158 women out of 5210 participants (41.4%) used at least one medication. Analgesics (paracetamol), systemic antihistamines (cetirizine), and drugs for gastric disorders (omeprazole) were the three most used classes. Anti-infectives were less prevalent than during pre-pandemic times. Antidepressants and anxiety related medication use remained similar, despite a higher prevalence of these symptoms. Self-medication was reported in 19.4% of women, and 4.1% of chronic medication users reported that they changed a chronic medication on personal initiative due to the pandemic. In conclusion, medication use patterns in our cohort were mostly similar to those of the first COVID-19 wave and the pre-pandemic period. More studies are needed to explore factors associated with self-medication and changes in chronic medication use due to the pandemic in this perinatal population. MDPI 2022-04-27 /pmc/articles/PMC9100043/ /pubmed/35564733 http://dx.doi.org/10.3390/ijerph19095335 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gerbier, Eva
Favre, Guillaume
Tauqeer, Fatima
Winterfeld, Ursula
Stojanov, Milos
Oliver, Alison
Passier, Anneke
Nordeng, Hedvig
Pomar, Léo
Baud, David
Panchaud, Alice
Meyer-Massetti, Carla
Ceulemans, Michael
Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
title Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
title_full Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
title_fullStr Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
title_full_unstemmed Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
title_short Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
title_sort self-reported medication use among pregnant and postpartum women during the third wave of the covid-19 pandemic: a european multinational cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100043/
https://www.ncbi.nlm.nih.gov/pubmed/35564733
http://dx.doi.org/10.3390/ijerph19095335
work_keys_str_mv AT gerbiereva selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT favreguillaume selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT tauqeerfatima selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT winterfeldursula selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT stojanovmilos selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT oliveralison selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT passieranneke selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT nordenghedvig selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT pomarleo selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT bauddavid selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT panchaudalice selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT meyermassetticarla selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy
AT ceulemansmichael selfreportedmedicationuseamongpregnantandpostpartumwomenduringthethirdwaveofthecovid19pandemicaeuropeanmultinationalcrosssectionalstudy